Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.
DISCUSSION: In order to fully evaluate the societal perspective of implementing platelet PRT, the increase in costs must be balanced against the expected benefits (prevention of transfusion-transmissible infections, white cell inactivation, extension of platelet storage, discontinuation of pathogen detection testing). Further studies based on actual numbers of platelet transfusion complications and their societal cost at a local level are needed to see the full cost to benefit ratio of platelet PRT implementation in Italy, and to promote equal treatment for all citizens.
PMID: 30201081 [PubMed - as supplied by publisher]
Source: Blood Transfusion - Category: Hematology Authors: Cicchetti A, Coretti S, Sacco F, Rebulla P, Fiore A, Rumi F, Di Bidino R, Urbina LI, Refolo P, Sacchini D, Spagnolo AG, Midolo E, Marano G, Farina B, Pati I, Veropalumbo E, Pupella S, Liumbruno GM Tags: Blood Transfus Source Type: research
More News: Blood Transusion | Budgets | Hematology | Italy Health | National Health Service (NHS) | Study | UK Health